(Z)-2-(5-((9-(4-nitrobenzyl)-9H-carbazol-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid

ID: ALA4210895

PubChem CID: 145966656

Max Phase: Preclinical

Molecular Formula: C25H17N3O5S2

Molecular Weight: 503.56

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CN1C(=O)/C(=C/c2ccc3c(c2)c2ccccc2n3Cc2ccc([N+](=O)[O-])cc2)SC1=S

Standard InChI:  InChI=1S/C25H17N3O5S2/c29-23(30)14-27-24(31)22(35-25(27)34)12-16-7-10-21-19(11-16)18-3-1-2-4-20(18)26(21)13-15-5-8-17(9-6-15)28(32)33/h1-12H,13-14H2,(H,29,30)/b22-12-

Standard InChI Key:  HHYQWBHIJNKKAM-UUYOSTAYSA-N

Molfile:  

     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
    2.6029  -12.7160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6017  -13.5355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3098  -13.9445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3080  -12.3071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0166  -12.7124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0214  -13.5310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8014  -13.7794    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7937  -12.4549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2744  -13.1127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0825  -13.0245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4109  -12.2791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9251  -11.6212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1188  -11.7127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0606  -14.5544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8614  -14.7175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1164  -15.4909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9163  -15.6541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4588  -15.0418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1958  -14.2636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3965  -14.1041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2516  -10.8720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0636  -10.7801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6136  -11.3816    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.3575  -11.0433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2656  -10.2313    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4649  -10.0679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1257   -9.3244    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0684  -11.4463    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.8685   -9.6796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6477   -9.9259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2506   -9.3742    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8240  -10.7238    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2633  -15.2051    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8041  -14.5925    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5235  -15.9798    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  9  1  0
  8  5  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  7 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 12 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 22  1  0
 26 27  2  0
 24 28  2  0
 25 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  2  0
 33 34  2  0
 33 35  1  0
 18 33  1  0
M  CHG  2  33   1  35  -1
M  END

Alternative Forms

  1. Parent:

    ALA4210895

    ---

Associated Targets(Human)

HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP2A Tclin DNA topoisomerase II alpha (6317 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Topoisomerase I (119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 503.56Molecular Weight (Monoisotopic): 503.0610AlogP: 5.04#Rotatable Bonds: 6
Polar Surface Area: 105.68Molecular Species: ACIDHBA: 7HBD: 1
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.90CX Basic pKa: CX LogP: 5.45CX LogD: 2.23
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.17Np Likeness Score: -1.44

References

1. Jiang H, Zhang WJ, Li PH, Wang J, Dong CZ, Zhang K, Chen HX, Du ZY..  (2018)  Synthesis and biological evaluation of novel carbazole-rhodanine conjugates as topoisomerase II inhibitors.,  28  (8): [PMID:29545100] [10.1016/j.bmcl.2018.03.017]

Source